Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

20 May 2003 : Original article  

Comparative efficacy of interferon therapy (IFT)in patients with chronic hepatitis C (CHC)depending on histological grade and stage

N. Matievskaya, N. Prokopchik, V. Tsyrkunov

Med Sci Monit 2003; 9(2): 11-12 :: ID: 15257

Abstract

Background:To compare the efficacy of IFT in patients depending on the histological activity degree and disease stage.Material/Methods: The results of IFT have been analysed in 50 patients with CHC.There are 40 males and 10 females in the studied group.Mean age of patients was 36.6 ±16.6.All the patients underwent liver biopsy before IFT and in 6 months after its accomplishment.The histological examination has been made according to Knodell scoring system.31 patients had CHC of mild activity (a necroinflammatory score was in range 1 –8),19 patients –of moderate activity (a necroinflammatory score was in range 9 –12).Fibrosis score of 0 was in 10 patients, fibrosis score of 1 –in 24 patients,fibrosis score of 3 –in 15 patients.All the patients were receiving monotherapy with a -2 b Interferon preparations within 6 months.The groups were compared according to biochemical response rate (BR),namely,reduction of ALT activity on the background of IFT,virological response (VR)–disappearance of RNA HCV after IFT course,morphological response (MR)–reduction of inflammation and fibrosis degree in the control biopsy.Results:The rate of BR did not differ significantly in patients with hepatitis of mild activity in comparison with ones who had hepatitis of moderate activity (25/31 v.6/19,respectively, p>0.05).VR was in 10/31 patients with hepatitis of mild activity v.4/19 patients with hepatitis of moderate activity (p>0.05),MR was in 30/31 patients with hepatitis of mild activity and in 6/19 patients with hepatitis of moderate activity (p>0.05).BR was found out evidently more frequently in patients with fibrosis 0 in comparison with the patients who had fibrosis 3 (9/10 patients v.6/15,respectively p0.3).VR was significantly more frequent in patients with fibrosis 0 as compared with the patients having fibrosis 1 and fibrosis 3(7/10 v.4/24,p0.05).Conclusions:1.Patients with chronic hepatitis C and progressive fibrosis stage had significantly low rate of BR and VR on IFT in comparison with ones who did not have fibrosis in liver biopsy,it should be taken into consideration while admi- nistering IFT.2.Histological activity degree did not influence on the efficacy of IFT in the studied group.

Add Comment 0 Comments

Editorial

01 April 2025 : Editorial  

Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to Humans

Dinah V. Parums

DOI: 10.12659/MSM.949109

Med Sci Monit 2025; 31:e949109

0:00

In Press

Clinical Research  

Use of The Mirror-Image Technique for Patient-Specific Reconstruction of Cuboid Fractures

Med Sci Monit In Press; DOI: 10.12659/MSM.947437  

Laboratory Research  

Retention of 3-D-Printed, Milled, and Conventionally Fabricated Occlusal Splints

Med Sci Monit In Press; DOI: 10.12659/MSM.947342  

Review article  

A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitor...

Med Sci Monit In Press; DOI: 10.12659/MSM.949300  

Clinical Research  

Buccal Acupuncture Reduces the Dose of Sufentanil Needed in Laparoscopic Gynecological Surgery

Med Sci Monit In Press; DOI: 10.12659/MSM.947088  

Most Viewed Current Articles

17 Jan 2024 : Review article   7,932,846

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,905

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   29,808

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   23,790

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750